Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)

Bioorg Med Chem Lett. 2006 Mar 1;16(5):1151-5. doi: 10.1016/j.bmcl.2005.11.086. Epub 2005 Dec 15.

Abstract

A series of novel pyrrolocarbazole lactams was identified as potent PARP-1 inhibitors in vitro and in a PC12 cellular NAD(+) depletion assay. The SAR trends of substituents at the 3-position, as well as the effect of blocking the indole or lactam NH-groups of the template by methylation or formylation, are discussed in relation to molecular modeling studies.

MeSH terms

  • Animals
  • Carbazoles / chemical synthesis
  • Carbazoles / chemistry*
  • Carbazoles / pharmacology*
  • Cell Membrane Permeability / drug effects
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Imides / chemistry
  • Inhibitory Concentration 50
  • Lactams / chemical synthesis
  • Lactams / chemistry*
  • Lactams / pharmacology*
  • Models, Molecular
  • PC12 Cells
  • Poly(ADP-ribose) Polymerase Inhibitors*
  • Poly(ADP-ribose) Polymerases / chemistry
  • Poly(ADP-ribose) Polymerases / metabolism
  • Protein Structure, Tertiary
  • Pyrroles / chemical synthesis
  • Pyrroles / chemistry*
  • Pyrroles / pharmacology*
  • Rats
  • Structure-Activity Relationship

Substances

  • Carbazoles
  • Enzyme Inhibitors
  • Imides
  • Lactams
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Pyrroles
  • Poly(ADP-ribose) Polymerases